Quasi drugs

 Latest update: July 2022 

Quasi-drugs are medicines for the purpose of prevention of symptoms and hygiene: they have a weaker effect on the human body than medicines. Some products, such as nutritional drinks, shampoos, and hair-growth products, are considered “quasi-drugs”, whereas skincare products that are less effective than “quasi-drugs” are classified as cosmetics.

This different category of products, which doesn't have an EU counterpart, imply vastly different standards and regulations than other pharmaceutical products. Pre-marketing approvals, registration of ingredients and means of manufacturing are highly regulated for these over-the counter products. Thus, EU companies need to consider a variety of new aspects for their implementation on the Japanese market.

National Consumer Affairs Center of Japan (NCACOJ), What is the difference between cosmetics and quasi-drugs? 2017 .
JPMA, Pharmaceutical Laws and Regulations in Japan


> For more information on Cosmetics, please visit our specific sectorial page


Table of Contents

  • Overview
  • Main regulating agencies
  • Regulation standards & Specific regulations
  • Future Outlook & Strategies
  • Expert Reports & Webinars
  • Annual Report
  • Further Readings
  • Relevant Organisations and Trade Fairs
Please log in for full access
Subscribe to
our newsletters

The EU-Japan Centre currently produces 5 newsletters :

  • EU-Japan NEWS - our flagship newsletter covering the Centre's support services, information about EU (or Member States) - Japan cooperation
  • Japanese Industry and Policy News
  • “About Japan” e-News (Only available for EU companies / EU organisations)
  • Japan Tax and Public Procurement Weekly Tender Digest (Only available for EU companies / EU organisations)
  • Tech Transfer Helpdesk Newsletter
1 EUR = 170,172 JPY